Patents 48show all

  • 28
    A61M - Devices for introducing media into, or onto, the body
  • 17
    A61K - Preparations for medical, dental, or toilet purposes
  • 16
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 10
    C12N - Microorganisms or enzymes
  • 8
    B01D - Separation
  • 1
    A61F - Filters implantable into blood vessels
  • 1
    A61L - Methods or apparatus for sterilising materials or objects in general
  • 1
    B33Y - Additive manufacturing, i.e. manufacturing of three-dimensional [3-d] objects by additive deposition, additive agglomeration or additive layering, e.g. by 3-d printing, stereolithography or selective laser sintering

Clinical Trials 3show all

2Phase 21Phase 1

SEC Filings show all


4
D

Contact Information

Ann Arbor, MI
United States

SEC Form D Funding Events

DateOfferedSoldType
2012-01-11$33,879,000$16,439,500Equity, Option to Acquire
2010-06-17$12,000,000$11,686,876Equity, Debt, Option to Acquire
2009-11-06$2,000,000$2,000,000Debt, Option to Acquire
2008-12-29Unknown Unknown Other (Paper Filing)

Key Executives

  • R. James Danehy
    Executive Officer, Director
  • Mark R. Morsfield
    Executive Officer
  • H. David Humes
    Director
  • Hugo Braun
    Director
  • Mina Patel Sooch
    Director
  • William White
    Director
  • R James Danehy
    Executive Officer, Director
  • Mark Morsfield
    Executive Officer
  • H David Humes
    Director
  • Peter DeComo
    Director
  • Kenneth Van Heel
    Director
  • Alvin Vitangcol
    Director
  • Leslie Bottorff
    Director